2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

…, X Mariette, I Padjen, JM PegoReigosa… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …

Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics versus American College of Rheumatology criteria. A comparative …

…, JM PegoReigosa, P Nero, M Cerqueira… - Arthritis care & …, 2015 - Wiley Online Library
Objective The new Systemic Lupus International Collaborating Clinics (SLICC) 2012
classification criteria aimed to improve the performance of systemic lupus erythematosus (SLE) …

Respiratory manifestations of systemic lupus erythematosus: old and new concepts

JM Pego-Reigosa, DA Medeiros… - Best practice & research …, 2009 - Elsevier
The respiratory system is commonly involved in systemic lupus erythematosus. Lung disorders
are classified as primary (due to lupus) and secondary to other conditions. Pleuritis and …

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review

…, E Loza-Santamaría, JM Pego-Reigosa… - Seminars in arthritis and …, 2014 - Elsevier
Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal systemic
lupus erythematosus (SLE). Methods We systematically searched MEDLINE, EMBASE …

Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis

…, S Muñoz-Fernández, JM Pego-Reigosa… - Rheumatology …, 2015 - Springer
To identify risk and predictors of lymphoma or lymphoproliferative disease in patients with
primary Sjögren syndrome. Articles were identified through a comprehensive search strategy …

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

…, I Parodis, JM Pego-Reigosa, M Petri… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the management of systemic lupus
erythematosus (SLE) based on emerging new evidence. Methods An international Task …

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

…, C Diaz-Torne, J Manero, JM Pego-Reigosa… - Annals of the …, 2020 - ard.bmj.com
From the beginning of the COVID-19 pandemic, more than 4.7 million cases have been
detected in the world, Spain being one of the countries hardest hit by the SARS-CoV-2. 1 The …

Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

…, FP Ruiz, A Juan-Mas, JM Pego-Reigosa… - … Clínica (English Edition), 2019 - Elsevier
Aims To describe the methodology of the EPISER 2016 (study of the prevalence of rheumatic
diseases in adult population in Spain), as well its strengths and limitations. The aim of this …

Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases

…, C Diaz-Lagares, JM Pego-Reigosa… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVES: To analyze the clinical characteristics, outcomes, and patterns of association
with the different biologic agents used in all reported cases of adult patients developing …

[HTML][HTML] Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

…, A Zea, JM Pego-Reigosa, M Freire… - Arthritis research & …, 2018 - Springer
Background Systemic lupus erythematosus (SLE) is a common systemic autoimmune
disease with a complex genetic inheritance. Genome-wide association studies (GWAS) have …